Differential Dependence of Hypoxia-inducible Factors 1α and 2α on mTORC1 and mTORC2
Top Cited Papers
Open Access
- 1 December 2008
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (50) , 34495-34499
- https://doi.org/10.1074/jbc.c800170200
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- A novel AKT3 mutation in melanoma tumours and cell linesBritish Journal of Cancer, 2008
- Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-RasCancer Letters, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Hypoxia-inducible factors: central regulators of the tumor phenotypeCurrent Opinion in Genetics & Development, 2007
- Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AMLBlood, 2006
- mTOR and cancer: insights into a complex relationshipNature Reviews Cancer, 2006
- Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancerNature Medicine, 2005
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005
- von Hippel-Lindau Tumor Suppressor Protein and Hypoxia-Inducible Factor in Kidney CancerAmerican Journal of Nephrology, 2004
- Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor GrowthPLoS Biology, 2003